Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 140,388
  • Shares Outstanding, K 45,433
  • Annual Sales, $ 111,010 K
  • Annual Income, $ -1,280 K
  • 60-Month Beta 1.61
  • Price/Sales 1.22
  • Price/Cash Flow 4.75
  • Price/Book 1.21
Trade ASRT with:

Options Overview Details

View History
  • Implied Volatility 98.51% ( -53.18%)
  • Historical Volatility 110.33%
  • IV Percentile 26%
  • IV Rank 30.50%
  • IV High 223.51% on 06/25/21
  • IV Low 43.64% on 10/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 171
  • Volume Avg (30-Day) 530
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 25,525
  • Open Int (30-Day) 25,599

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.07
  • Number of Estimates 2
  • High Estimate 0.09
  • Low Estimate 0.04
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +121.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.86 +67.20%
on 05/09/22
3.27 -4.89%
on 05/23/22
+0.97 (+45.33%)
since 04/27/22
3-Month
1.86 +67.20%
on 05/09/22
3.52 -11.62%
on 04/11/22
+0.74 (+31.22%)
since 02/25/22
52-Week
0.85 +265.37%
on 10/06/21
3.52 -11.62%
on 04/11/22
+1.32 (+73.74%)
since 05/27/21

Most Recent Stories

More News
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

ASRT : 3.11 (+0.65%)
ZTS : 172.10 (+3.74%)
Tenet Healthcare (THC) Unit Conifer Offers Services to Brookwood

Tenet Healthcare's (THC) unit Conifer inks an agreement with Brookwood Baptist Health to deliver enhanced revenue cycle services to four of the remaining hospitals of the latter across Central Alabama....

THC : 66.37 (+1.30%)
AMN : 95.63 (+2.01%)
LNTH : 70.34 (+6.33%)
ASRT : 3.11 (+0.65%)
4 Top-Rated Stocks Under $10 to Buy This Month

Though the major stock market indexes made a comeback yesterday following statements from the Biden administration hinting at the possibility of removing U.S tariffs on China, concerns over surging inflation...

ASRT : 3.11 (+0.65%)
CO : 2.46 (+3.80%)
OSG : 2.23 (+4.21%)
SXC : 8.19 (-1.80%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 0.9466 (+2.63%)
LPTH : 1.6900 (+1.20%)
RCAT : 2.06 (+1.48%)
IONM : 2.13 (-4.92%)
PYR : 2.44 (+7.02%)
OSS : 4.20 (+3.45%)
MODD : 4.76 (+5.08%)
STRN : 2.16 (+1.89%)
AEYE : 3.30 (+0.61%)
SMFL : 0.4900 (+3.16%)
LFMD : 2.30 (+2.22%)
SURG : 4.93 (+2.92%)
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

ASRT : 3.11 (+0.65%)
SRTS : 8.96 (+0.22%)
Sidoti May Virtual Micro Cap Investor Conference

- Presentation Times and Weblinks Released for Over 60 Presenting Companies - Wednesday and Thursday, May 11th-12th, 2022 NEW YORK, NY / ACCESSWIRE / May 10, 2022 / Sidoti & Company, LLC has released the...

YTRA : 1.7900 (+3.47%)
REAX : 1.5200 (+4.11%)
INTT : 7.46 (-0.13%)
HSON : 37.25 (-0.90%)
SIFY : 2.22 (+4.72%)
BSET : 16.63 (+4.99%)
MNOW.VN : 0.630 (unch)
LINC : 6.08 (+1.16%)
DPSI : 5.40 (+7.78%)
CVGI : 6.72 (+2.75%)
ASRT : 3.11 (+0.65%)
HELE : 183.83 (+0.71%)
Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of 122.22% and 10.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ASRT : 3.11 (+0.65%)
BBI : 0.1595 (+2.05%)
Assertio Reports First Quarter 2022 Financial Results

Reaffirms Full Year Net Product Sales and Raises Full Year Non-GAAP Adjusted EBITDA Guidance Net Product Sales Up 37% and Non-GAAP Adjusted EBITDA Up 52%...

ASRT : 3.11 (+0.65%)
Assertio (ASRT) Outpaces Stock Market Gains: What You Should Know

Assertio (ASRT) closed at $2.23 in the latest trading session, marking a +1.36% move from the prior day.

ASRT : 3.11 (+0.65%)
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?

On Assertio Holdings' (ASRT) Q1 earnings call, investors will focus on the sales performance of its marketed products.

NVAX : 55.29 (+17.46%)
ACET : 11.75 (+14.52%)
ATRS : 5.59 (unch)
ASRT : 3.11 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 3.24
2nd Resistance Point 3.18
1st Resistance Point 3.15
Last Price 3.11
1st Support Level 3.05
2nd Support Level 2.99
3rd Support Level 2.96

See More

52-Week High 3.52
Last Price 3.11
Fibonacci 61.8% 2.50
Fibonacci 50% 2.19
Fibonacci 38.2% 1.87
52-Week Low 0.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar